![Susan Sobolov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Sobolov currently works at Subintro Ltd., as Director from 2022, Caelum Biosciences, Inc., as Chief Operating Officer from 2019, and RIGImmune, Inc., as President & Chief Operating Officer.
| Unternehmen | Position | Beginn |
|---|---|---|
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders | Geschäftsführer | 01.03.2019 |
Subintro Ltd.
 Subintro Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops and delivers antiviral therapeutics | Direktor/Vorstandsmitglied | 18.08.2022 |
RIGImmune, Inc.
 RIGImmune, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biopharmaceutical research company that develops RNA immunotherapies | Präsident | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Caelum Biosciences, Inc.
Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders | Health Technology |
RIGImmune, Inc.
RIGImmune, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biopharmaceutical research company that develops RNA immunotherapies | Commercial Services |
Subintro Ltd.
Subintro Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops and delivers antiviral therapeutics | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
